MT-0814

· Senju Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MT-0814, covering 2021-04-20 to 2021-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability and Effectiveness of MT-0814 for the Treatment of Age-related Macular Degeneration [Phase 2]

See pricing